Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer. — SciRadar

Back to results

The Lancet. Oncology

The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.

Alexander D Sherry, Krishan R Jethwa, Pavlos Msaouel, Ethan B Ludmir

Published: 202610.1016/S1470-2045(25)00666-7

No abstract available for this study.